Evidence map›Paper›PMID 23185362›Full record

ArticlePloS one2012

Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides.

Mehrnoosh Doroudchi, Oleg Yegorov, Tom Baumgartner, Anne-Elen Kernaleguen, Gaelle Breton, Michel L Ndongala, Mohamed-Rachid Boulassel, Jean-Pierre Routy, Nicole F Bernard, Rafick-Pierre Sékaly and 1 more

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mehrnoosh DoroudchiLaboratoire d'Immunologie, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) Saint-Luc, Montréal, Québec, Canada.
Oleg Yegorov
Tom Baumgartner
Anne-Elen Kernaleguen
Gaelle Breton
Michel L Ndongala
Mohamed-Rachid Boulassel
Jean-Pierre Routy
Nicole F Bernard
Rafick-Pierre Sékaly
Bader Yassine-Diab

Funding

FACTORS CONTROLLING T CELL RESPONSE IN PRIMARY HIVR01AI043261 · NIAID · UNIVERSITY OF MONTREAL · PI SEKALY, RAFICK-PIERRE · 1999 to 2006
$1.8M
CIHR HGC-14975NIAID NIH HHS 2 R01 AI043261NIAID NIH HHS R01 AI043261
6 · The paper itself

Abstract

objectiveTo determine the function and phenotype of CD8(+) T-cells targeting consensus and autologous sequences of entire HIV-1 Nef protein.

methodsMultiparameter flow cytometry-based analysis was used to evaluate the responses of two treatment naïve HIV-infected individuals, during primary and the chronic phases of infection.

resultsA greater breadth and magnitude of CD8 IFN-γ responses to autologous compared to clade-B consensus peptides was observed in both subjects. Cross recognition between autologous and consensus peptides decreased in both subjects during progression from primary to chronic infection. The frequencies of TEMRA and TEM CD8(+) T-cells targeting autologous peptides were higher than those targeting consensus peptides and were more polyfunctional (IFN-γ(+) Gr-B(+) CD107a(+)).

conclusionsOur data indicate superior sensitivity and specificity of autologous peptides. The functional and maturational aspects of "real" versus "cross-recognized" responses were also found to differ, highlighting the importance of a sequence-specific approach towards understanding HIV immune response.

Indexed as

CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFlow CytometryGranzymesHistocompatibility Antigens Class IHIV-1HumansImmune SystemInterferon-gammaLeukocytes, MononuclearLysosomal-Associated Membrane Protein 1Mutationnef Gene Products, Human Immunodeficiency VirusPeptidesSequence Analysis, DNAStaphylococcus aureusGranzymesHistocompatibility Antigens Class IInterferon-gammaLysosomal-Associated Membrane Protein 1nef Gene Products, Human Immunodeficiency VirusPeptides

Identifiers

PMID23185362
PMCPMC3501503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.